Related Experiment Video
Updated: Sep 13, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Understanding variability in cell death modes and sensitivity: Potential implications for targeted cancer therapies
Magdalena Węgrzyn1, Malgorzata Adamiec-Organisciok1, Anahit Dawicka1
1Department of Systems Biology and Engineering, The Silesian University of Technology, Akademicka Street 16, 44-100, Gliwice, Poland; Biotechnology Centre, Silesian University of Technology, Krzywoustego Street 8, 44-100, Gliwice, Poland.
None:
Cell death is an inseparable mechanism accompanying the individual development of multicellular organisms. In every organism, there must be a constant exchange and regulation of the number of cells in tissues, consisting of the control of their proliferation, inhibition of the cell cycle, or induction of cell death pathways. The proper functioning of the physiological mechanisms of cell death (e.g., apoptotic) determines the maintenance of homeostasis, understood as the internal balance of the body, which directly depends on the appropriate pH levels, osmotic pressure, or concentration of individual chemical compounds. Regulated cell death (RCD) plays an important role in the body's homeostasis, but in case of its disruption, and without control over the regulation of one or more types of cell death, it can cause diseases such as cancer, neurodegeneration, and autoimmune diseases. RCD can take many forms, including apoptosis, necroptosis, or ferroptosis. This review focuses the variability in dominant modes of cell death, sensitivity, and response pathways across different tumor cell lines. Understanding these dynamics is essential for optimizing novel treatment modalities and improving cancer's patient prognosis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers

